Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium by Israel, JS, Marcelin, L, Thomas, C, Szczyrbová, E, Fuessel, S, Puhr, M, Linxweiler, J, Yalala, S, Zwart, WT, Baniahmad, A, van Goubergen, J, Itkonen, HM, Sharp, A, O’Neill, E, Pretze, M, Miederer, M, Erb, HH

A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer by Warren, A, Massie, C, Watt, K, Luko, K, Orafidiya, F, Selth, L, Mohammed, H, Chohan, B, Menon, S, Baridi, A, Zhao, W, Escriu, C, Pungsrinont, T, D'Santos, C, Yang, X, Taylor, C, Qureshi, A, Zecchini, V, Shaw, G, Dehm, S, Mills, I, Carroll, J, Tilley, W, McEwan, I, Baniahmad, A, Neal, D, Asim, M

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. by Asim, M, Tarish, F, Zecchini, HI, Sanjiv, K, Gelali, E, Massie, CE, Baridi, A, Warren, AY, Zhao, W, Ogris, C, McDuffus, L-A, Mascalchi, P, Shaw, G, Dev, H, Wadhwa, K, Wijnhoven, P, Forment, JV, Lyons, SR, Lynch, AG, O'Neill, C, Zecchini, VR, Rennie, PS, Baniahmad, A, Tavaré, S, Mills, IG, Galanty, Y, Crosetto, N, Schultz, N, Neal, D, Helleday, T